Latest stories on CMND
Clearmind Medicine enrolls first patients with AUD in CMND-100 trial
The Fly58 · neutralproduct/pr
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
Business Insider56 · neutralproduct/pr
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
GlobeNewswire56 · neutralproduct/pr
Clearmind Medicine Inc. GAAP EPS of -$0.57
Seeking Alpha28 · bearishearnings
Clearmind Medicine announces Yale IRB approval of Parts B, C of CMND-100 trial
The Fly63 · neutralproduct/pr
Clearmind Medicine Agrees to Acquire 51% Stake in Charging Robotics for $2.5 Million
InvestorsHub58 · neutralm&a
Clearmind Medicine to acquire 51% stake in Charging Robotics
The Fly63 · neutralm&a
Clearmind Medicine signs agreement to acquire 51% stake in Charging Robotics
Seeking Alpha63 · neutralm&a
Psychedelic: Clearmind initiates Phase IIa of CMND-100 trial
The Fly56 · neutralproduct/pr
Clearmind Medicine initiates next stage of CMND-100 trial for treatment of AUD
The Fly59 · neutralproduct/pr
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
StockTitan63 · neutralproduct/pr
Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment
The Fly56 · neutralproduct/pr
SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination
The Fly55 · neutralproduct/pr
Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
StockTitan63 · neutralproduct/pr
Clearmind Medicine reports MEAI development program permeation study results
The Fly59 · neutralproduct/pr
Clearmind Medicine Reports Dsmb Approves Advancing Phase I Ii Aud Study
The Fly59 · neutralproduct/pr
Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
StockTitan63 · neutralproduct/pr
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
StockTitan67 · bullishproduct/pr